株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

放射線治療の世界市場の予測 〜2020年:技術 (体外 (IGRT・IMRT・VMAT・定位照射)・ブラキセラピー (LDR・HDR)・全身)・製品 (サイバーナイフ・ガンマナイフ・リニアック・陽子線)・用途 (前立腺癌・乳癌など) 別

Radiotherapy Market by Technology: External (IGRT, IMRT, VMAT, Stereotactic), Brachytherapy (LDR & HDR), Systemic Radiotherapy), Product (Cyberknife, Gammaknife, Linac, Proton Beam), & Application (Prostate & Breast Cancer) - Global Forecasts to 2020

発行 MarketsandMarkets 商品コード 344382
出版日 ページ情報 英文 179 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
放射線治療の世界市場の予測 〜2020年:技術 (体外 (IGRT・IMRT・VMAT・定位照射)・ブラキセラピー (LDR・HDR)・全身)・製品 (サイバーナイフ・ガンマナイフ・リニアック・陽子線)・用途 (前立腺癌・乳癌など) 別 Radiotherapy Market by Technology: External (IGRT, IMRT, VMAT, Stereotactic), Brachytherapy (LDR & HDR), Systemic Radiotherapy), Product (Cyberknife, Gammaknife, Linac, Proton Beam), & Application (Prostate & Breast Cancer) - Global Forecasts to 2020
出版日: 2016年01月18日 ページ情報: 英文 179 Pages
概要

世界の放射線治療の市場は2015年から2020年にかけて6.2%のCAGRで推移し、2015年の55億8500万米ドルから、2020年には75億4480万米ドルの規模に成長すると予測されています。2015年の市場シェアは地域別で北米地域が最大となり、治療法/技術別では外照射の部門が最大のシェアを記録しています。

当レポートでは、世界の放射線治療の市場を調査し、市場影響因子および市場機会の分析、製品/技術の詳細区分別の市場動向および市場成長予測、地域別の動向、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界の放射線治療市場の推移と予測
  • 世界の放射線治療市場の規模:実績・予測
  • 体外照射療法市場の実績・予測:技術別
  • 世界市場の規模:用途別

第5章 市場概要

  • イントロダクション
  • 市場区分
    • 製品別
    • 技術別
    • 用途別
  • 市場動態
    • 成長促進要因
    • 成長阻害要因
    • 市場機会
    • 課題

第6章 市場分析:製品別

  • イントロダクション
  • 体外照射療法
    • イントロダクション
    • LINAC (リニアック)
    • 小型高度放射線治療システム
      • イントロダクション
      • サイバーナイフ
      • ガンマナイフ
      • トモセラピー
    • 陽子線治療システム
      • サイクロトロン
      • シンクロトロン
  • 内部放射線治療
    • イントロダクション
    • シード
    • アプリケーター・アフタローダー
    • ブラキセラピー
  • 全身放射線療法

第7章 市場分析:技術別

  • イントロダクション
  • 体外照射療法
    • イントロダクション
    • 画像誘導放射線治療 (IGRT)
    • 強度変調放射線治療 (IMRT)
    • 定位放射線治療技術
    • 粒子線/陽子線治療
    • トモセラピー
    • 3次元原体照射 (3D-CRT)
    • 強度変調回転照射 (VMAT)
  • 内部放射線治療
    • イントロダクション
    • 低線量率放射線療法
    • 高線量率放射線療法
  • 全身放射線療法

第8章 市場分析:用途別

  • イントロダクション
  • 体外照射療法
    • イントロダクション
    • 前立腺癌
    • 乳癌
    • 肺癌
    • 頭頚部癌
    • 直腸癌
    • その他
  • 内部放射線治療/ブラキセラピー
    • イントロダクション
    • 前立腺癌
    • 婦人科系の癌
    • 乳癌
    • 子宮頸癌
    • 陰茎癌
    • その他

第9章 地域市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他
    • ラテンアメリカ
    • 中東
    • アフリカ

第10章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向
    • 新製品の投入・製品の強化
    • 合意・提携・協力・契約
    • M&A
    • 地域的拡張
    • その他

第11章 企業プロファイル

  • イントロダクション
  • VARIAN MEDICAL SYSTEMS, INC.
  • ELEKTA AB
  • ACCURAY INCORPORATED
  • IBA (ION BEAM APPLICATIONS SA)
  • NORDION, INC.
  • C. R. BARD, INC.
  • ISORAY MEDICAL, INC.
  • RAYSEARCH LABORATORIES AB
  • MEVION MEDICAL SYSTEMS, INC.
  • 三菱電機
    • 概要
    • 財務動向
    • 製品・サービス
    • 戦略
    • 発展動向、など

第12章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 1773

The global radiotherapy market is expected to reach USD 7,544.8 million by 2020 from USD 5,585.0 million in 2015, at a CAGR of 6.2% between 2015 and 2020. North America is expected to hold the largest share of the global radiotherapy market in 2015. By product, application, and technology, the radiotherapy market is broadly segmented into external beam radiotherapy, internal radiotherapy/brachytherapy, and systemic radiation therapy. The external beam radiotherapy segment accounts for the largest share of the radiotherapy market in 2015, and is expected to grow at the highest rate.

Geographically, the report covers four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global radiotherapy market in 2015, followed by Europe. Asia-Pacific radiotherapy market is poised to witness highest growth rate during the forecast period from 2015 to 2020 due to a number of factors including improving healthcare infrastructure and supportive government activities.

Market growth is majorly driven by the technological advancements in radiotherapy products, rise in number of geriatric population, increasing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy, and growing adoption of radiotherapy devices and procedures.

As of 2014, the global radiotherapy market was dominated by Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), and Accuray Incorporated (U.S.), which together held a share of 84.5% of the overall radiotherapy market. New product launches & product enhancements; agreements, collaborations, partnerships, and contracts; geographic expansions; strategic acquisitions; and others (awareness campaigns and offering research fund & grants) are the major strategies adopted by most market players to achieve growth in the global radiotherapy market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis -market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the radiotherapy market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on radiotherapy products offered by the top 10 players in the radiotherapy devices market. The report analyzes the radiotherapy market by product, application, and technology
  • Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, product enhancements, and new product launches in the radiotherapy market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various radiotherapy devices across four geographies
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the radiotherapy market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Breakdown of primaries
      • 2.1.2.2. Key data from primary sources
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
      • 2.2.1.1. Bottom-up approach
      • 2.2.1.2. Top-down approach
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL RADIOTHERAPY MARKET (2015-2020)
  • 4.2. GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT (2015 VS. 2020)
  • 4.3. EXTERNAL BEAM RADIATION THERAPY MARKET, BY TECHNOLOGY (2015 VS. 2020)
  • 4.4. GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION (2015)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. RADIOTHERAPY MARKET, BY PRODUCT
    • 5.2.2. RADIOTHERAPY MARKET, BY TECHNOLOGY
    • 5.2.3. RADIOTHERAPY MARKET, BY APPLICATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Technological advancements
      • 5.3.1.2. Growing number of cancer patients
      • 5.3.1.3. Rapidly increasing aging population
      • 5.3.1.4. Rising adoption of radiotherapy devices and procedures
      • 5.3.1.5. Increasing number of symposiums spreading awareness about the benefits of radiotherapy
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Lack of adequate infrastructure & healthcare expenditure
      • 5.3.2.2. Shortage of trained personnel
      • 5.3.2.3. Unfavourable healthcare reforms in the United States
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging markets offer numerous growth opportunities
      • 5.3.3.2. Increasing demand for cancer treatment driving investments in radiotherapy
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Difficulty in visualizing tumors
      • 5.3.4.2. Affordability and accessibility of treatment

6. RADIOTHERAPY MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. EXTERNAL BEAM RADIATION THERAPY
    • 6.2.1. INTRODUCTION
    • 6.2.2. ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS (LINAC)
    • 6.2.3. COMPACT ADVANCED RADIOTHERAPY SYSTEMS
      • 6.2.3.1. Introduction
      • 6.2.3.2. CyberKnife
      • 6.2.3.3. Gamma Knife
      • 6.2.3.4. TomoTherapy
    • 6.2.4. PROTON THERAPY SYSTEMS
      • 6.2.4.1. Cyclotron
      • 6.2.4.2. Synchrotron
  • 6.3. INTERNAL RADIATION THERAPY
    • 6.3.1. INTRODUCTION
    • 6.3.2. SEEDS
    • 6.3.3. APPLICATORS AND AFTERLOADERS
    • 6.3.4. ELECTRONIC BRACHYTHERAPY
  • 6.4. SYSTEMIC RADIATION THERAPY

7. RADIOTHERAPY MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. EXTERNAL BEAM RADIATION THERAPY
    • 7.2.1. INTRODUCTION
    • 7.2.2. IMAGE-GUIDED RADIOTHERAPY (IGRT)
    • 7.2.3. INTENSITY MODULATED RADIOTHERAPY (IMRT)
    • 7.2.4. STEREOTACTIC TECHNOLOGY
    • 7.2.5. PARTICLE/PROTON BEAM THERAPY
    • 7.2.6. TOMOTHERAPY
    • 7.2.7. 3D-CONFORMAL RADIOTHERAPY (3D-CRT)
    • 7.2.8. VOLUMETRIC MODULATED ARC THERAPY
  • 7.3. INTERNAL BEAM RADIATION THERAPY
    • 7.3.1. INTRODUCTION
    • 7.3.2. LOW-DOSE RATE RADIOTHERAPY
    • 7.3.3. HIGH DOSE RATE RADIOTHERAPY
  • 7.4. SYSTEMIC RADIATION THERAPY

8. GLOBAL RADIOTHERAPY MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. EXTERNAL BEAM RADIATION THERAPY
    • 8.2.1. INTRODUCTION
    • 8.2.2. PROSTATE CANCER
    • 8.2.3. BREAST CANCER
    • 8.2.4. LUNG CANCER
    • 8.2.5. HEAD AND NECK CANCER
    • 8.2.6. COLORECTAL CANCER
    • 8.2.7. OTHERS
  • 8.3. INTERNAL RADIATION THERAPY/BRACHYTHERAPY
    • 8.3.1. INTRODUCTION
    • 8.3.2. PROSTATE CANCER
    • 8.3.3. GYNECOLOGICAL CANCER
    • 8.3.4. BREAST CANCER
    • 8.3.5. CERVICAL CANCER
    • 8.3.6. PENILE CANCER
    • 8.3.7. OTHERS

9. RADIOTHERAPY MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
  • 9.3. EUROPE
  • 9.4. ASIA-PACIFIC
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. LATIN AMERICA
    • 9.5.2. MIDDLE EAST
    • 9.5.3. AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
    • 10.3.2. AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS
    • 10.3.3. MERGERS AND ACQUISITIONS
    • 10.3.4. GEOGRAPHIC EXPANSIONS
    • 10.3.5. OTHER DEVELOPMENTS

11. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 11.1. INTRODUCTION
  • 11.2. VARIAN MEDICAL SYSTEMS, INC.
  • 11.3. ELEKTA AB
  • 11.4. ACCURAY INCORPORATED
  • 11.5. IBA (ION BEAM APPLICATIONS SA)
  • 11.6. NORDION, INC.
  • 11.7. C. R. BARD, INC.
  • 11.8. ISORAY MEDICAL, INC.
  • 11.9. RAYSEARCH LABORATORIES AB
  • 11.10. MEVION MEDICAL SYSTEMS, INC.
  • 11.11. MITSUBISHI ELECTRIC CORPORATION

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE*
  • 12.2. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.3. AVAILABLE CUSTOMIZATIONS
  • 12.4. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 2: EXTERNAL BEAM RADIATION THERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 3: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 4: ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 5: COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 6: COMPACT ADVANCED RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 7: CYBERKNIFE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 8: GAMMA KNIFE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: TOMOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: PROTON THERAPY SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 11: PROTON THERAPY SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: CYCLOTRON MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: SYNCHROTRON MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: INTERNAL RADIATION THERAPY/BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 15: INTERNAL RADIOTHERAPY/BRACHYTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: SEEDS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: APPLICATORS AND AFTERLOADERS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: ELECTRONIC BRACHYTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: SYSTEMIC RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 21: EXTERNAL BEAM RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 22: EXTERNAL BEAM RADIATION THERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: IMAGE-GUIDED RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: STEREOTACTIC TECHNOLOGY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: PARTICLE/PROTON BEAM MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: TOMOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: 3-D CONFORMAL RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: VOLUMETRIC ARC RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 30: INTERNAL RADIATION THERAPY/BRACHYTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 31: INTERNAL RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: LOW DOSE RATE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: HIGH DOSE RATE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: SYSTEMIC RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 36: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 37: PROSTATE CANCER MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 38: BREAST CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: LUNG CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 40: HEAD AND NECK CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 41: COLORECTAL CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 42: OTHER CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 43: INTERNAL RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 44: PROSTATE CANCER MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 45: GYNECOLOGICAL CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 46: BREAST CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 47: CERVICAL CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 48: PENILE CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 49: OTHER CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 50: RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 51: NORTH AMERICA: RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 52: NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 53: NORTH AMERICA: COMPACT ADVANCED RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 54: NORTH AMERICA: PROTON THERAPY SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 55: NORTH AMERICA: INTERNAL RADIOTHERAPY/BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 56: NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 57: NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 58: NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 59: NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 60: EUROPE: RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 61: EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 62: EUROPE: COMPACT ADVANCED RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 63: EUROPE: PROTON THERAPY SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 64: EUROPE: INTERNAL RADIOTHERAPY/BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 65: EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 66: EUROPE: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 67: EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 68: EUROPE: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 69: APAC: RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 70: APAC: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 71: APAC: COMPACT ADVANCED RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 72: APAC: PROTON THERAPY SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 73: APAC: INTERNAL RADIOTHERAPY/BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 74: APAC: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 75: APAC: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 76: APAC: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 77: APAC: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 78: ROW: RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 79: ROW: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 80: ROW: COMPACT ADVANCED RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 81: ROW: PROTON THERAPY SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 82: ROW: INTERNAL RADIOTHERAPY/BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 83: ROW: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 84: ROW: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 85: ROW: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 86: ROW: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 87: TOP 5 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2013-2015
  • TABLE 88: TOP 5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS, 2013-2015
  • TABLE 89: TOP MERGERS AND ACQUISITIONS, 2013-2015
  • TABLE 90: TOP 5 GEOGRAPHIC EXPANSIONS, 2013-2015
  • TABLE 91: TOP 5 OTHER DEVELOPMENTS, 2013-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: RADIOTHERAPY MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: RADIOTHERAPY MARKET: TOP-DOWN APPROACH
  • FIGURE 5: RADIOTHERAPY MARKET: DATA TRIANGULATION
  • FIGURE 6: GLOBAL RADIOTHERAPY MARKET, BY TECHNOLOGY, 2015 (USD MILLION)
  • FIGURE 7: GLOBAL RADIOTHERAPY MARKET, BY TECHNOLOGY, 2015 VS. 2020
  • FIGURE 8: GLOBAL RADIOTHERAPY MARKET, BY REGION, 2015 (USD MILLION)
  • FIGURE 9: ATTRACTIVE GROWTH OPPORTUNITIES IN THE RADIOTHERAPY MARKET
  • FIGURE 10: EXTERNAL BEAM THERAPY SEGMENT IS EXPECTED TO DOMINATE THE RADIOTHERAPY MARKET TILL 2020
  • FIGURE 11: VMAT AND TOMOTHERAPY ARE EXPECTED TO BE FASTEST GROWING AMONG THE KEY TECHNOLOGIES OF EXTERNAL BEAM RADIATION THERAPY MARKET
  • FIGURE 12: PROSTATE CANCER TREATMENT TO COMMAND THE LARGEST SHARE OF KEY APPLICATIONS FOR BOTH EXTERNAL AND INTERNAL RADIOTHERAPY
  • FIGURE 13: RADIOTHERAPY MARKET, BY PRODUCT
  • FIGURE 14: RADIOTHERAPY MARKET, BY TECHNOLOGY
  • FIGURE 15: RADIOTHERAPY MARKET, BY APPLICATION
  • FIGURE 16: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: GROWING INCIDENCES OF CANCER
  • FIGURE 18: TOTAL POPULATION VS. AGING POPULATION
  • FIGURE 19: GROWING INCIDENCES OF CANCER ARE EXPECTED TO PROPEL MARKET GROWTH
  • FIGURE 20: NUMBER OF RADIOTHERAPY UNITS IN DIFFERENT REGIONS
  • FIGURE 21: SHORTAGE OF TRAINED ONCOLOGISTS AND RADIOGRAPHERS LIMITS THE MARKET GROWTH
  • FIGURE 22: EMERGING MARKETS TO OFFER NUMEROUS OPPORTUNITIES
  • FIGURE 23: AFFORDABILITY AND ACCESSIBILITY OF RADIOTHERAPY HINDERS MARKET GROWTH
  • FIGURE 24: LINAC DOMINATES THE EXTERNAL BEAM RADIOTHERAPY SYSTEMS MARKET
  • FIGURE 25: VOLUMETRIC MODULATED ARC RADIOTHERAPY IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING 2015 TO 2020
  • FIGURE 26: HIGH DOSE RATE RADIOTHERAPY IS EXPECTED TO GAIN SIGNIFICANT MARKET SHARE BY 2020
  • FIGURE 27: BREAST CANCER IS EXPECTED TO BE FASTEST GROWING AMONG THE KEY APPLICATIONS OF EXTERNAL BEAM RADIATION THERAPY MARKET
  • FIGURE 28: PENILE CANCER IS EXPECTED TO BE FASTEST GROWING AMONG THE KEY APPLICATIONS OF INTERNAL RADIATION THERAPY MARKET
  • FIGURE 29: GLOBAL RADIOTHERAPY MARKET SHARE (%) AND SIZE (USD MILLION)
  • FIGURE 30: NORTH AMERICAN RADIOTHERAPY MARKET SNAPSHOT
  • FIGURE 31: HIGH ADOPTION OF ADVANCED RADIOTHERAPY TECHNOLOGIES DRIVES THE NORTH AMERICAN RADIOTHERAPY MARKET
  • FIGURE 32: EUROPEAN RADIOTHERAPY MARKET SNAPSHOT
  • FIGURE 33: GROWING INCIDENCES OF CANCER LEADING TO INCREASED DEMAND FOR RADIOTHERAPY PROCEDURES IN THE EUROPEAN REGION
  • FIGURE 34: ASIA-PACIFIC RADIOTHERAPY MARKET SNAPSHOT
  • FIGURE 35: KEY MARKET PLAYERS TO EXPAND THEIR PRESENCE IN THE ASIA-PACIFIC REGION
  • FIGURE 36: REST OF THE WORLD RADIOTHERAPY MARKET SNAPSHOT
  • FIGURE 37: GROWING INCIDENCES OF CANCER IN THE ROW REGION IS LEADING TO INCREASING DEMAND FOR RADIOTHERAPY PROCEDURES
  • FIGURE 38: LEADING MARKET PLAYERS ADOPTED BOTH ORGANIC AND INORGANIC GROWTH STRATEGIES OVER THE LAST THREE YEARS (2013-2015)
  • FIGURE 39: GLOBAL RADIOTHERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 40: GEOGRAPHIC REVENUE MIX OF THE TOP FOUR MARKET PLAYERS* (2014)
  • FIGURE 41: VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
  • FIGURE 42: ELEKTA AB: COMPANY SNAPSHOT
  • FIGURE 43: ACCURAY INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 44: IBA: COMPANY SNAPSHOT
  • FIGURE 45: C.R. BARD, INC.: COMPANY SNAPSHOT
  • FIGURE 46: ISORAY MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 47: RAYSEARCH LABORATORIES AB: COMPANY SNAPSHOT
  • FIGURE 48: MITSUBISHI ELECTRIC CORPORATION: COMPANY SNAPSHOT
Back to Top